Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 1.000 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.518 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.517 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.516 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.511 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.510 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.500 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.499 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.499 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.498 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.493 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.491 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.487 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.485 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.485 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.482 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.482 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.482 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.481 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.478 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.477 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
| 4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.474 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.473 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.473 | |
| 3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.471 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.471 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.471 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.471 | |
| 4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.470 | |
| 3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.470 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.469 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.469 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.468 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
| 3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.466 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.465 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.464 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.464 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.464 | |
| 4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
| 1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.461 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.461 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.461 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.459 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.458 | |
| 3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.457 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.456 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.456 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.456 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.455 | |
| 3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.455 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.455 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.455 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
| 3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.454 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.454 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.453 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.453 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.453 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.452 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.451 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.451 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.451 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.450 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.450 | |
| 4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.450 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.450 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.449 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.449 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.449 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.449 | |
| 3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.448 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
| 2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.447 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.447 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.447 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.446 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.446 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.446 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.445 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.445 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.445 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.444 | |
| 3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.444 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.442 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.441 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.440 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.440 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3jqp | A2P | Ferredoxin--NADP reductase, apicoplast | / | 0.440 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.440 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.440 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.440 |